Lv5
950 积分 2023-10-18 加入
C-KIT Signaling in Cancer Treatment
1天前
待确认
Pegylation
18天前
已完结
PEGylated antibodies and antibody fragments for improved therapy: a review
19天前
已完结
Mode of Nipocalimab Action and Pharmacology in Cells and Preclinical Models
2个月前
已关闭
Nipocalimab a High Affinity, Immunoselective Clinical FcRn Blocker with Unique Properties: Observations from Non-clinical and Clinical Studies (P4-14.008)
2个月前
已关闭
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
2个月前
已完结
A passionate kiss, then run: exocytosis and recycling of IgG by FcRn
2个月前
已完结
Comparing the Lectin and Mass Spectrometry-Based Approaches to Quantify Galactose-Deficient IgA1 in IgA Nephropathy
3个月前
已关闭
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases
4个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
4个月前
已完结
皖公网安备34019202002308
